- call +1-201-465-4211
- email sales@mrinsights.biz
Diabetes mellitus is a group of a metabolic disorder caused when the body is unable to produce required quantity of Insulin. Insulin is a hormone secreted by beta cells of the islet of Langerhans of the pancreas. Various symptoms associated with diabetes disorder include recurrent urination, increased thirst, and hunger. Diabetes can cause much chronic complication if left untreated. Some of them include acute complications like diabetic ketoacidosis, chronic kidney failure, foot ulcers, and damage to the eyes.
Scope of the Report:
The worldwide market for Oral Antidiabetic Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Oral Antidiabetic Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Eli Lilly
Abbott
Biocon
Sanofi
Sunpharma
Novartis
Novo Nordisk
Merck
Pfizer
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Sulfonylureas
Meglitinides
Alpha-glucosidase inhibitors
Market Segment by Applications, can be divided into
Hospitals
Clinics
Others
There are 15 Chapters to deeply display the global Oral Antidiabetic Drugs market.
Chapter 1, to describe Oral Antidiabetic Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Oral Antidiabetic Drugs, with sales, revenue, and price of Oral Antidiabetic Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Oral Antidiabetic Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Oral Antidiabetic Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Oral Antidiabetic Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Oral Antidiabetic Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Sulfonylureas
1.2.2 Meglitinides
1.2.3 Alpha-glucosidase inhibitors
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Clinics
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Eli Lilly
2.1.1 Business Overview
2.1.2 Oral Antidiabetic Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Eli Lilly Oral Antidiabetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Abbott
2.2.1 Business Overview
2.2.2 Oral Antidiabetic Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Abbott Oral Antidiabetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Biocon
2.3.1 Business Overview
2.3.2 Oral Antidiabetic Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Biocon Oral Antidiabetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Sanofi
2.4.1 Business Overview
2.4.2 Oral Antidiabetic Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sanofi Oral Antidiabetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Sunpharma
2.5.1 Business Overview
2.5.2 Oral Antidiabetic Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Sunpharma Oral Antidiabetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Novartis
2.6.1 Business Overview
2.6.2 Oral Antidiabetic Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Novartis Oral Antidiabetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Novo Nordisk
2.7.1 Business Overview
2.7.2 Oral Antidiabetic Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Novo Nordisk Oral Antidiabetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Merck
2.8.1 Business Overview
2.8.2 Oral Antidiabetic Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Merck Oral Antidiabetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Pfizer
2.9.1 Business Overview
2.9.2 Oral Antidiabetic Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Pfizer Oral Antidiabetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Oral Antidiabetic Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Oral Antidiabetic Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Oral Antidiabetic Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Oral Antidiabetic Drugs Manufacturer Market Share in 2017
3.3.2 Top 6 Oral Antidiabetic Drugs Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Oral Antidiabetic Drugs Market Analysis by Regions
4.1 Global Oral Antidiabetic Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Oral Antidiabetic Drugs Sales and Market Share by Regions (2013-2018)
4.1.2 Global Oral Antidiabetic Drugs Revenue and Market Share by Regions (2013-2018)
4.2 North America Oral Antidiabetic Drugs Sales and Growth Rate (2013-2018)
4.3 Europe Oral Antidiabetic Drugs Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Oral Antidiabetic Drugs Sales and Growth Rate (2013-2018)
4.5 South America Oral Antidiabetic Drugs Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Oral Antidiabetic Drugs Sales and Growth Rate (2013-2018)
5 North America Oral Antidiabetic Drugs by Countries
5.1 North America Oral Antidiabetic Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Oral Antidiabetic Drugs Sales and Market Share by Countries (2013-2018)
5.1.2 North America Oral Antidiabetic Drugs Revenue and Market Share by Countries (2013-2018)
5.2 United States Oral Antidiabetic Drugs Sales and Growth Rate (2013-2018)
5.3 Canada Oral Antidiabetic Drugs Sales and Growth Rate (2013-2018)
5.4 Mexico Oral Antidiabetic Drugs Sales and Growth Rate (2013-2018)
6 Europe Oral Antidiabetic Drugs by Countries
6.1 Europe Oral Antidiabetic Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Oral Antidiabetic Drugs Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Oral Antidiabetic Drugs Revenue and Market Share by Countries (2013-2018)
6.2 Germany Oral Antidiabetic Drugs Sales and Growth Rate (2013-2018)
6.3 UK Oral Antidiabetic Drugs Sales and Growth Rate (2013-2018)
6.4 France Oral Antidiabetic Drugs Sales and Growth Rate (2013-2018)
6.5 Russia Oral Antidiabetic Drugs Sales and Growth Rate (2013-2018)
6.6 Italy Oral Antidiabetic Drugs Sales and Growth Rate (2013-2018)
7 Asia-Pacific Oral Antidiabetic Drugs by Countries
7.1 Asia-Pacific Oral Antidiabetic Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Oral Antidiabetic Drugs Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Oral Antidiabetic Drugs Revenue and Market Share by Countries (2013-2018)
7.2 China Oral Antidiabetic Drugs Sales and Growth Rate (2013-2018)
7.3 Japan Oral Antidiabetic Drugs Sales and Growth Rate (2013-2018)
7.4 Korea Oral Antidiabetic Drugs Sales and Growth Rate (2013-2018)
7.5 India Oral Antidiabetic Drugs Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Oral Antidiabetic Drugs Sales and Growth Rate (2013-2018)
8 South America Oral Antidiabetic Drugs by Countries
8.1 South America Oral Antidiabetic Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Oral Antidiabetic Drugs Sales and Market Share by Countries (2013-2018)
8.1.2 South America Oral Antidiabetic Drugs Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Oral Antidiabetic Drugs Sales and Growth Rate (2013-2018)
8.3 Argentina Oral Antidiabetic Drugs Sales and Growth Rate (2013-2018)
8.4 Colombia Oral Antidiabetic Drugs Sales and Growth Rate (2013-2018)
9 Middle East and Africa Oral Antidiabetic Drugs by Countries
9.1 Middle East and Africa Oral Antidiabetic Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Oral Antidiabetic Drugs Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Oral Antidiabetic Drugs Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Oral Antidiabetic Drugs Sales and Growth Rate (2013-2018)
9.3 UAE Oral Antidiabetic Drugs Sales and Growth Rate (2013-2018)
9.4 Egypt Oral Antidiabetic Drugs Sales and Growth Rate (2013-2018)
9.5 Nigeria Oral Antidiabetic Drugs Sales and Growth Rate (2013-2018)
9.6 South Africa Oral Antidiabetic Drugs Sales and Growth Rate (2013-2018)
10 Global Oral Antidiabetic Drugs Market Segment by Type
10.1 Global Oral Antidiabetic Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Oral Antidiabetic Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Oral Antidiabetic Drugs Revenue and Market Share by Type (2013-2018)
10.2 Sulfonylureas Sales Growth and Price
10.2.1 Global Sulfonylureas Sales Growth (2013-2018)
10.2.2 Global Sulfonylureas Price (2013-2018)
10.3 Meglitinides Sales Growth and Price
10.3.1 Global Meglitinides Sales Growth (2013-2018)
10.3.2 Global Meglitinides Price (2013-2018)
10.4 Alpha-glucosidase inhibitors Sales Growth and Price
10.4.1 Global Alpha-glucosidase inhibitors Sales Growth (2013-2018)
10.4.2 Global Alpha-glucosidase inhibitors Price (2013-2018)
11 Global Oral Antidiabetic Drugs Market Segment by Application
11.1 Global Oral Antidiabetic Drugs Sales Market Share by Application (2013-2018)
11.2 Hospitals Sales Growth (2013-2018)
11.3 Clinics Sales Growth (2013-2018)
11.4 Others Sales Growth (2013-2018)
12 Oral Antidiabetic Drugs Market Forecast (2018-2023)
12.1 Global Oral Antidiabetic Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Oral Antidiabetic Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Oral Antidiabetic Drugs Market Forecast (2018-2023)
12.2.2 Europe Oral Antidiabetic Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Oral Antidiabetic Drugs Market Forecast (2018-2023)
12.2.4 South America Oral Antidiabetic Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Oral Antidiabetic Drugs Market Forecast (2018-2023)
12.3 Oral Antidiabetic Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Oral Antidiabetic Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Oral Antidiabetic Drugs Market Share Forecast by Type (2018-2023)
12.4 Oral Antidiabetic Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Oral Antidiabetic Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Oral Antidiabetic Drugs Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Oral Antidiabetic Drugs Picture
Table Product Specifications of Oral Antidiabetic Drugs
Figure Global Sales Market Share of Oral Antidiabetic Drugs by Types in 2017
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
